Skip to main navigation Skip to search Skip to main content

Colombian consensus on the care of critically ill patients with suspected or confirmed severe yellow fever

  • Alex Julián Forero-Delgadillo (First Author)
  • , Jeison Andrés Morales-Olivera (Second Author)
  • , Julián Fernando Celis-Guzmán (Third Author)
  • , Omar Eduardo Zapata-Díaz (Fourth Autor)
  • , Gustavo Adolfo González-Varona (Fifth Author)
  • , Camilo Alberto Acevedo-Bedoya
  • , Rómulo Salazar-Fernández
  • , Jaime Orlando Ordoñez
  • , Henry Robayo-Amortegui
  • , Alejandro Quintero-Altare
  • , Diana Catalina Ramírez-Reyes
  • , Juan Diego Melo-Pedraza
  • , Juan Olivella-Gomez
  • , Jessica María Forero
  • , Abraham Katime-Zuñiga
  • , Wilmer E. Villamil-Gomez
  • , Alfonso J. Rodriguez-Morales
  • , Ricardo Buitrago-Bernal
  • , Fernando Bozza
  • , Luis Felipe Reyes (Correspondent Author)
  • Hospital Federico Lleras Acosta
  • Universidad del Tolima
  • Fundación Clínica Shaio
  • University of Oxford

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Abstract

Yellow fever is an arboviral disease transmitted by Aedes, Haemagogus and Sabethes mosquitoes. It features both urban and jungle transmission cycles. Its incidence has risen in Colombia due to deforestation, human expansion, and climate change. The disease can progress from a nonspecific febrile stage to a severe intoxication phase, characterised by multiple organ failure and high mortality rates. This consensus establishes criteria for early identification and management of severe yellow fever and recommendations for admission to the Intensive Care Unit in cases of liver dysfunction, kidney failure, or shock. An individualised haemodynamic resuscitation strategy is emphasised to avoid volume overload and not delay the use of norepinephrine in persistent hypotension. Additionally, we recommend addressing haematological and respiratory complications, including platelet transfusion restrictions and strict intra-abdominal pressure monitoring. In more severe cases, plasma exchange and renal replacement therapies are recommended. Based on evidence and the GRADE methodology, implementing these strategies aims to improve survival and reduce morbidity in critically ill yellow fever patients.

Original languageEnglish
Article number101144
Pages (from-to)1-10
Number of pages10
JournalThe Lancet Regional Health - Americas
Volume48
DOIs
StatePublished - Aug 2025

Strategic Focuses

  • Vida Humana Plena (Vita)​

Article Classification

  • Full research article

Indexación Internacional (Artículo)

  • ISI Y SCOPUS

Scopus-Q Quartil

  • Q1

ISI- Q Quartil

  • Q1

Categoría Publindex

  • A1

Fingerprint

Dive into the research topics of 'Colombian consensus on the care of critically ill patients with suspected or confirmed severe yellow fever'. Together they form a unique fingerprint.

Cite this